Therapixel announces two new FDA clearances for its most advanced breast cancer screening AI solution
Therapixel, maker of MammoScreen, has announced that it has received two new FDA 510(k) clearances, resulting in the release of its most comprehensive breast cancer screening AI. With a set of powerful new features, MammoScreen goes beyond suspicious lesion...